logo
Israel's plan to ‘conquer' Gaza is leaving Palestinians with little place to go: 5 maps show how

Israel's plan to ‘conquer' Gaza is leaving Palestinians with little place to go: 5 maps show how

CNNa day ago

Even before Israel's war in Gaza started, the territory was one of the most densely populated places on the planet, described by United Nations officials as an 'open-air prison.' Now, Israeli forces are expanding their operations, cramming the population into an ever-shrinking patch of land.
Israel's latest military offensive, named 'Gideon's Chariots,' aims to finally 'conquer' the territory, as one government minister put it. Almost 80% of the enclave has come under evacuation orders or been designated as a militarized zone since March 18 when Israel broke its ceasefire with Hamas, according to the UN. Since then, Israel has a declared policy – backed by the US – to encourage resettlement of Gaza's residents.
As part of the 'intensified operation,' Israeli Prime Minister Benjamin Netanyahu said the whole population of Gaza – around 2 million people – will be displaced to the south of the 140 square-mile territory.
The Israeli military claims the operation is aimed at destroying Hamas and freeing hostages. Meanwhile, Israel's far-right Finance Minister Bezalel Smotrich said the operation could lead to a complete takeover of the territory.
'We are finally going to conquer the Gaza Strip,' he said after Israel's security cabinet approved the expanded campaign.
See what Israel's expanding operation means on the ground, in five maps.
Some Gazans in the north say they have fled to the nearby coastline in a last-ditch effort to escape the renewed bombardment, exhausted by Israel's 19-month assault. Others are sleeping in tents surrounded by the rubble of their former homes, fearful to leave in case they are forced out of Gaza.
Since Israel broke the ceasefire in mid-March, at least 2-3 kilometers (1.2-1.9 miles) into Gaza's land border is a no-go zone, which includes a 1 kilometer-wide (around 0.6 miles) buffer area next to Israeli territory where homes, factories and farmland have been systematically levelled.
Access to the Mediterranean Sea to fish is all but banned. According to the UN Food and Agriculture Organization (FAO), most fishing boats have been destroyed and Palestinians fishing meters from the shore have been targeted.
Another militarized corridor was established in early April — the Israeli-demarcated 'Morag Corridor' in Rafah — with the stated intention of 'dividing the strip.' This is one of at least four routes established to control Gaza by the Israeli military who demolish and clear all buildings and cropland to make way for them.
At least 31 evacuation orders have been issued by Israeli forces since March 18 this year covering large areas of the strip, sometimes at the rate of two a day. As a result, an estimated 600,000 people in Gaza have been displaced in that time (this figure includes people who may have been displaced multiple times), according to the United Nations-led Site Management Cluster.
Evacuation orders aren't necessarily permanent, but Israel has not stated how long they are active. CNN has asked the Israeli military if the orders expire and how that information is shared with people in Gaza but has not received a reply.
In northern Gaza, these orders have recently been accompanied by instructions to move south, despite ongoing attacks there too. This week, the Israeli military issued evacuation orders for most of southern Gaza with directives to head toward the Al-Mawasi area, ahead of what its spokesperson said would be an 'unprecedented attack.'
Aid groups have criticized the use of these directives, branding them as confusing, often inaccurate and overly reliant on an internet connection which most people in Gaza only have intermittent access to. The delivery mechanism is varied, with some receiving text messages or phone calls ahead of an attack, while for others the first sign is incoming Israeli fire. On the ground, Gaza no longer looks familiar to residents, with most landmarks destroyed or damaged, including shops, trees and roads, making it much more difficult to navigate. In order to move around, people need to pass through heavily militarized checkpoints, usually on foot.
'There's no place for my children and me to sleep, and I don't know what to do,' Iman Al Agha, a mother of six who said she was forced out of the northern city of Beit Lahia when Israeli quadcopters started shooting at her and her family, told CNN last week.
'I've been on the street with my children for three days, and I can't find a place to settle,' she said. 'I wish for death at any moment. I don't know what to do with my children or where this life will take us. There is no solution.'
Since Israel launched its war in Gaza following Hamas' deadly October 2023 attacks, Gazans have been displaced an average of six times – some up to 19 times – according to the Danish Refugee Council.
For many, repeated displacement means reliving the trauma of generations uprooted by what Palestinians call al-Nakba, or 'the catastrophe,' when roughly 700,000 Palestinians fled or were expelled from their homes in historic Palestine, during the creation of Israel in 1948.
Most of the remaining areas that are not under evacuation orders or militarized are heavily damaged. A assessment by the CUNY Graduate Center found 60% of buildings are destroyed while the United Nations Relief and Works Agency for Palestine Refugees (UNRWA) said 92% of homes have either been damaged or destroyed. According to the UN Satellite Centre, 68% of roads are also damaged, which adds to the complications of transporting aid around the strip.
Of the agricultural land, a report published in the Journal of Science of Remote Sensing found around 80% of tree crops — such as olives and fruit trees — are likely damaged, as well as 65% of greenhouses used to grow food such as tomatoes, cucumbers, peppers and strawberries. The FAO has also reported that all cropland in Rafah, and nearly all cropland in the northern governorates are not accessible.
Al-Mawasi, where many people have been instructed to go by the Israeli military, is a narrow coastal strip in southern Gaza. Once rural farmland, by February it was the most populated area in Gaza with an estimated 116,000 people, almost 6% of the enclave's population, displaced there, according to the UN Office for the Coordination of Humanitarian Affairs.
Sufficient shelter is now incredibly scarce in Gaza. Omar Alsaqqa, a Gaza resident who works for aid group Médecins Sans Frontières in Khan Younis, said in a statement provided to CNN that there are no tents left and no space for people to set up.
'I don't know what to answer when colleagues ask me where they can go with their children in the middle of the night. We are running out of options to stay alive,' he said.
Nada Siyam, a displaced woman who gave birth in her tent in Gaza City last week, told CNN that there isn't even a bed for her newborn, Eid, to sleep on. 'My child is two days old and is suffering from the heat. There are many mosquitoes and rats all around us. We live in the streets amidst all this filth,' she said.
Further south, aid workers say they are overstretched, burnt out and fearful that they won't be able to provide adequate care for a potential influx of more uprooted people.
Beginning on March 2, an 11-week blockade stopped all humanitarian aid from entering the strip. In the past week, some aid has entered through the southern Kerem Shalom crossing, but humanitarian agencies say food has yet to reach the over half a million people currently facing starvation across Gaza. 'It remains far from enough to meet the soaring humanitarian needs,' UN spokesperson Stéphane Dujarric said.
Medical facilities are already experiencing critical shortages of 'almost all essential materials, from basic consumables to infection prevention and control, to life-saving medications,' Summer Al Jamal, who works at Nasser Hospital on the outskirts of Khan Younis for UK-based charity Medical Aid for Palestinians, told CNN last week.
'If military operations continue, the existing health facilities will simply not be able to cope with the numbers of displaced people,' Al Jamal said.
They are also facing an 'overwhelming number of cases that require urgent, specialized medical care. Care that we can no longer provide,' Al Jamal added, while recalling how a 10-year-old boy who recently suffered head trauma in an airstrike that killed his family could not be treated as the medication he needed is no longer available in Gaza.
'If the situation remains unchanged, we do not expect to receive any medical supplies in the near future,' she said.
As well as medical aid, experts say Israel's displacement plans will necessitate the significant restructuring of Gaza's water supply system, much of which has already been destroyed or damaged since the war began.
'By forcing the population to move around… will further complicate access to water because new water points will have to be set up, new routes, new water trucking,' Wim Zwijnenburg, who analyses the environmental impact of conflicts for the Dutch peace organization PAX, told CNN.
In southern Gaza, the 140,000 litres of fuel needed weekly to maintain water supply operations was not received last week, leading to warnings from local officials of an imminent full-scale shutdown, the UN reported on May 21.
'The situation is especially dire in Al-Mawasi, which is not connected to the water network,' the UN said, adding that the area depends entirely on water being delivered via trucks.
There are hundreds of truckloads worth of water, sanitation and hygiene supplies stuck outside of the strip ready to cross the border 'at any moment once allowed in,' UNICEF told CNN on Thursday.
Israel's displacement plans have received international backlash in recent weeks, with the leaders of the United Kingdom, France, and Canada threatening to take 'concrete actions,' including sanctions, if Israel does not stop its latest military operations and continues to block aid from entering Gaza.
Netanyahu has vowed to push forward with the fresh offensive: 'At the end of the operation all areas of the strip will be under Israeli security control,' he said last Wednesday.
Meanwhile, despite everything, some Gazans plan to resist Israel's latest directives.
'This is our land, and we will not leave it. We will resist, and we live on our land,' Abdul Naser Siyam, who shares a makeshift tent with 22 other people in northern Gaza, told CNN. 'Just imagine how it would be if we left and went to the land of others.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025
ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025

Yahoo

timean hour ago

  • Yahoo

ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025

– Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) – – Padeliporfin VTP treatment continues to be safe and well-tolerated, establishing profile consistent with prior results alongside additional follow-up in Maintenance Treatment Phase (MTP) – – Interim analysis follows evaluation of 50% of target enrollment in study; completion of enrollment anticipated in 2H25 with topline data by year end – – Selected for late-breaking podium presentation today at 1:15 PM CT – TEL AVIV, Israel, May 31, 2025 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid tumors, today announced updated interim results from ENLIGHTED, the Company's ongoing Phase 3 study of Padeliporfin VTP treatment in patients with low-grade upper tract urothelial cancer (UTUC). These data will be presented in a late-breaking podium session at the at the American Society of Clinical Oncology Annual Meeting taking place May 30 – June 3, 2025, in Chicago, Illinois. 'We are pleased to share this interim analysis, now capturing 50% of target enrollment in ENLIGHTED, which continues to reinforce Padeliporfin VTP's best-in-class potential in low-grade UTUC,' said Eyal Morag, M.D., Chief Medical Officer of ImPact Biotech. 'We believe the emerging profile – a non-invasive treatment option delivering robust and sustained surgery-like efficacy, but without the associated risk of organ injury or loss – presents clear advantages over the standard of care. We are urgently progressing development to bring underserved UTUC patients this paradigm-shifting treatment and look forward to announcing potentially registrational topline data, including a view into durability, in UTUC within the year.' Key results from the interim analysis of the Phase 3 ENLIGHTED study of Padeliporfin VTP: As of November 5, 2024, the data cut-off for the poster presentation at ASCO, 43 patients had begun treatment, of which 37 had completed ITP and were evaluable for efficacy. Clinical Profile: 27 of the 37 (73%) response-evaluable patients achieved a CR at the end of ITP. 5 of the 37 (13.5%) response-evaluable patients achieved a partial response (PR) at the end of ITP. Safety and Tolerability Profile: Padeliporfin VTP was well-tolerated with a safety profile consistent with the previous data obtained from the Phase 1 study and previously announced preliminary Phase 3 results. Adverse events (AEs): the majority of treatment-emergent adverse events (TEAEs) were mild or moderate and were primarily URS related, resolving within a few days. The most common Grade 3 serious adverse events related to VTP treatment were hematuria, dysuria and flank pain, which resolved within a few days. No TEAEs of special interest were reported and no TEAE led to discontinuation of the study treatment. ImPact continues to recruit for the ENLIGHTED study and expects to complete enrollment in the second half of 2025. The company anticipates the presentation of topline ENLIGHTED data in 2025. Podium Presentation Details: Poster Title: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC): ENLIGHTED phase 3 studyPresenter: Vitaly Margulis, Professor of Urologic Oncology, University of Texas Southwestern Medical CenterPoster Number: LBA4513Session Title: Bladder Cancer: Upper Tract Transitional Cell CarcinomaSession Date & Time: May 31, 2025, 1:15 PM CT About ENLIGHTEDThe Phase 3 ENLIGHTED study is a single arm, non-randomized, open-label, pivotal trial evaluating Padeliporfin VTP for the treatment of low-grade UTUC. Across 29 clinical sites globally, ImPact is targeting enrollment of up to 100 patients with new or recurrent low-grade, non-invasive UTUC of the kidney or ureter. The study consists of two parts – an Induction Treatment Phase (ITP) and Maintenance Treatment Phase (MTP) – across which Padeliporfin, a photosensitizing drug, is administered intravenously and VTP therapy is performed, via an outpatient endoscopy which applies a laser fiber illumination for 10 minutes in the proximity of the tumor, leading to local activation of Padeliporfin in the tumor. ITP consists of one-to-three treatments with VTP therapy at four-week intervals or until a complete response (CR) is achieved; MTP follows with standard-of-care follow-up visits every three months with optional VTP therapy administered on each visit for up to 12 months. The study's primary objective is to assess the response rate to Padeliporfin VTP treatment at the end of ITP, with secondary objectives evaluating safety, tolerability and duration of response. About ImPact BiotechImPact Biotech is an advanced clinical-stage oncology company focused on the development and commercialization of Padeliporfin Vascular Targeted Photodynamic (VTP) therapy, a minimally invasive drug-device combination for selective ablation of unresectable solid tumors. The novel VTP platform delivers non-thermal laser light via optical fibers to locally activate Padeliporfin in the tumor microenvironment. Padeliporfin VTP is currently being evaluated in a pivotal Phase 3 study in low-grade upper tract urothelial carcinoma (UTUC) with earlier stage studies ongoing or planned in high-grade UTUC, pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC). The Company has longstanding collaborations with the Weizmann Institute of Science and Memorial Sloan Kettering Cancer Center and operations in the EU, Israel and the US. For more on ImPact Biotech Ltd., visit: and the ENLIGHTED clinical trial website (for the US): Contacts Global Head of Business DevelopmentGuy Precision AQJohn in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

AP PHOTOS: An AP photographer captures the moment an Israeli airstrike slammed into Gaza City
AP PHOTOS: An AP photographer captures the moment an Israeli airstrike slammed into Gaza City

San Francisco Chronicle​

timean hour ago

  • San Francisco Chronicle​

AP PHOTOS: An AP photographer captures the moment an Israeli airstrike slammed into Gaza City

GAZA CITY, Gaza Strip (AP) — An Associated Press photographer captured the moment an Israeli airstrike slammed into a building in Gaza City, showing a rare glimpse of the devastation Israeli air power has had on the Palestinian territory during the 19-month war with Hamas. Jehad Alshrafi's photos show a fireball, a massive cloud of smoke and people running away after Sunday's strike. Israel had warned residents before hitting the building, and there were no reports of casualties. The target of the strike was not known. ___ This is a photo gallery curated by AP photo editors.

AP PHOTOS: An AP photographer captures the moment an Israeli airstrike slammed into Gaza City
AP PHOTOS: An AP photographer captures the moment an Israeli airstrike slammed into Gaza City

Associated Press

timean hour ago

  • Associated Press

AP PHOTOS: An AP photographer captures the moment an Israeli airstrike slammed into Gaza City

GAZA CITY, Gaza Strip (AP) — An Associated Press photographer captured the moment an Israeli airstrike slammed into a building in Gaza City, showing a rare glimpse of the devastation Israeli air power has had on the Palestinian territory during the 19-month war with Hamas. Jehad Alshrafi's photos show a fireball, a massive cloud of smoke and people running away after Sunday's strike. Israel had warned residents before hitting the building, and there were no reports of casualties. The target of the strike was not known. ___ This is a photo gallery curated by AP photo editors.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store